Announcements Trials
Browse Landscape

Status

Completed 44Recruiting 14Active not recruiting 9Terminated 8Unknown 6Withdrawn 5No longer available 2Approved for marketing 2Suspended 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Expanded_access 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Prostatic Neoplasms 2Prostatic Diseases 1

Interventions

gallium 68 PSMA-11 2Oxaliplatin 2Magnetic Resonance Spectroscopy 2Fluorouracil 2motexafin gadolinium 1glucarpidase 1Positron-Emission Tomography 1Leucovorin 1Laparoscopy 1Gemtuzumab 1Gadolinium 1Carboxypeptidases 1Amifampridine 13-Iodobenzylguanidine 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Approved for marketing × OTHER × gallium 68 PSMA-11 × Clear all
NCT04452136 2022-03-14

Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate Cancer

OHSU Knight Cancer Institute

Approved for marketing
Genitourinary

Prostatic Diseases, Prostatic Neoplasms

NCT04377152 2021-03-01

Expanded Access 68Gallium-PSMA-11 PET for Prostate Cancer

University of California, San Francisco

Approved for marketing
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡